Curemark Enrolls First Patients in Phase III Clinical Trials for Autism... ( RYE N.Y. Oct. 14 /- Curemark LLC a dr...)

Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment

Date:10/14/2009

RYE, N.Y., Oct. 14 /PRNewswire/ -- Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.

CM-AT is based on research by Curemark founder and CEO Dr. Joan Fallon that showed enzyme deficiencies in autistic children, resulting in an inability to digest protein. The inability to digest protein affects the production of amino acids, the building blocks of chemicals essential for brain function.

"We are very excited to be enrolling our first children in the Phase III trials for CM-AT. Our progress with the clinical trials culminates years of research resulting in the breakthrough discovery of this therapy for children with autism," Fallon said. "We're hopeful that CM-AT will be one of the first therapies to address the underlying physiology of autism, rather than just treat its symptoms."

A new study released in early October by the U.S. Centers for Disease Control (CDC) showed that the number of children affected by autism is much higher than originally thought. According to the study, autism affects 1 in 91 children and about 1 in 58 boys, totaling an estimated 673,000 or approximately 1% of all children in the U.S.

For information on participating in the trials, log on to www.clinicaltrials.gov and search "Curemark."

About CUREMARK LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial pr
'/>"/>

SOURCE Curemark, LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Curemark Appoints Preeminent Pediatrics Gastroenterologist
2. Curemark Closes Series A Financing
3. Curemark CEO Presents at Epigenomics Conference
4. Curemark Announces Senior Executive Promotions
5. Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
6. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
7. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
8. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
9. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
10. Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
11. Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial

Post Your Comments:

(Date:5/21/2013)... May 21, 2013 Kepner-Tregoe (KT), the ... that 13-year veteran Chris Geraghty ... experience includes more than 20 years serving the ... manufacturing organizations. He succeeds Ray Baxter ... Kepner-Tregoe,s Chairman of the Board and CEO. ...

(Date:5/21/2013)... , May 21, 2013 Armada Health ... of the new Armada corporate website ( www.armadahealthcare.com ... communicate Armada,s unique and first-to-market services and its ... focused on the specialty pharmacy industry. ... of the Armada business model in delivering an ...

(Date:5/21/2013)... May 21, 2013 Hurel Corporation ("Hurel"), a ... cell-based assay platforms, today announced the appointment of ... the Company,s Board of Directors. Dr. MacDonald is the ... Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical development ... Merck & Co. in 2009. Over a ...

Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2 Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3 Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2 Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2

[0] Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer [0] Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace [0] Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors

... EORTC 40983 (EPOC),Intergroup Study Results, CHICAGO, June ... phase III EORTC 40983 Intergroup study, or ... peri-operative (pre and post,surgery) FOLFOX4 (Eloxatin(R) (oxaliplatin ... for colon cancer,5-fluorouracil/leucovorin (5-FU/LV)) given to patients ...

... Phase II Study Results Presented at Society ... 04, 2007 /PRNewswire-FirstCall/ --,Immunomedics, Inc. , a ... treat cancer and other serious,diseases, today announced ... with the radioisotope,iodine-131, was found to be ...

The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases

(Date:5/21/2013)... Medical Ministry International announced today that it has ... GreatNonprofits , the leading provider of user reviews about nonprofit ... 2013 Nonprofit,” says Samuel Smith, MMI CEO. This does ... and Staff serving in 22 countries around the world. This ... have seen our work first hand and wanted to tell ...

(Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... protecting the rights of victims injured by defective medical devices, ... attorney in the case of the Estate of Fred E. ... Kitsap County (Port Orchard). A May 21, 2013, Bloomberg ... Intuitive Surgical had acted like a “car dealership” in how ...

(Date:5/21/2013)... Antonio, TX (PRWEB) May 21, 2013 ... from the Texas Department of Aging and Disability Services. ... visits and employee interviews, ContinuCare Home Health was ... , The review is part of the Department of ... array of aging and disability services, supports and ...

(Date:5/21/2013)... May 21, 2013 HealthSmart continues to ... national presence has required the hiring of new talent ... is pleased to announce that Dawn Powell has joined ... as the Director of Account Management in the Central ... in Irving, Texas. With extensive client management, employee benefits, ...

(Date:5/21/2013)... stent, which is a novel stent platform eluting ... the Xience Prime everolimus-eluting stent for the primary ... nine months in the results of an imaging ... BIOFLOW-II substudy used intravascular ultrasound (IVUS) and optical ... and stent apposition at nine months after treating ...

Breaking Medicine News(10 mins):Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2 Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2 Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3 Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2 Health News:New Talent Joins the HealthSmart Account Management Team 2 Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2

[0] Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org [0] Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership [0] ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services [0] New Talent Joins the HealthSmart Account Management Team [0] Biodegradable stent proves non-inferior to drug-eluting stent

... site, Best Branded ... WEST CONSHOHOCKEN, Pa., March 10 Cadient Group, ... today it has received multiple nominations for the 2008,DTC ... the DTC,National Advertising Awards Dinner on April 17, 2008., ...

... 8 a.m. EDT, SHENZHEN, China, March 10 /Xinhua-PRNewswire-FirstCall/ ... ("Nepstar" or "the Company"), the,largest drugstore chain in China ... that it will report financial results for the,fourth quarter ... market,opens on March 19, 2008., The Company will ...

... and SUZHOU, China, March 10 ,Wyeth (NYSE: ... $280 million to,build a state-of-the-art nutritional manufacturing facility ... facility will primarily,produce infant formula milk powder and ... one of the world,s largest nutritional,manufacturing facilities., ...

... Conn., March 10 Therap Services announces,the appointment ... Services is a web-based service bureau offering an ... Therap has a,customer support team consisting of former ... "We are happy to have Anna in ...

... Scientists funded by the Biotechnology and Biological Sciences ... the journal Molecular Pharmacology identifying the structure of ... such as epilepsy and pre-menstrual tension. The same ... sensitive to alcohol. , The University of Cambridge ...

... after breathing, stretching program still evident 3 months ... -- Yoga helps ease hot flashes and other menopausal ... , Some of the 37 women who,d had early ... of Awareness" program, while others were assigned to a ...

Cached Medicine News:Health News:Cadient Group Receives Multiple Nominations for 2008 DTC National Advertising Awards 2 Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 2 Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 3 Health News:Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China 2 Health News:Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China 3 Health News:Therap Services Welcomes Anna Keith to the US Customer Support Team 2 Health News:Scientists determine structure of brain receptor implicated in epilepsy and PMT 2 Health News:Yoga Eases Menopause Symptoms in Breast Cancer Survivors 2

Cadient Group Receives Multiple Nominations for 2008 DTC National Advertising Awards China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China Therap Services Welcomes Anna Keith to the US Customer Support Team Scientists determine structure of brain receptor implicated in epilepsy and PMT Yoga Eases Menopause Symptoms in Breast Cancer Survivors

... Eyes enzymatic cleaner is a ... removes stubborn deposits in as ... eyes enzymatic cleaner contains an ... irritating film on soft contact ...

... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...

Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....

Titanium. Straight shafts with curved lower tip. Upper tip fits into positioning hole while lower jaw stabilizes the lens. Flat smooth handle with dull finish. Most popular size or model....

Medicine Products:

Sensitive Eyes Enzymatic Cleaner Wet-Field Hemostatic Eraser Bipolar Tip (20-23 gauge Tapered/Blunt Point, Straight)Wet-Field Hemostatic Eraser Bipolar Tip (20 gauge Straight, Long Shaft)Simcoe Implantation Forceps II